EMAS position statement: Thyroid disease and menopause

• DOI: 10.1016/j.maturitas.2024.107991
• Publication Date: 2024-04-24T04:44:42Z
• Authors: Gesthimani Mintziori; Stavroula Veneti; Kris Poppe; Dimitrios G. Goulis; Eleni Armeni; C. Tamer Erel; Ivan Fistonić; Timothy Hillard; Angelica Lindén H...; Blazej Meczekalski; Nicolás Mendoza; Alfred O. Mueck; Tommaso Simoncini; Petra Stute; Dorenda van Dijken; Margaret Rees; Leonidas Duntas; Irene Lambrinoudaki

Thyroid diseases are common in women in their late reproductive years; therefore, thyroid disease and menopause may co-exist. Both conditions may present with a wide range of symptoms, leading to diagnostic challenges and delayed diagnosis. Aim To construct the first European Menopause and Andropause Society (EMAS) statement on thyroid diseases and menopause.Literature review and consensus of expert opinion (EMAS executive board members/experts on menopause and thyroid disease).This position paper highlights the diagnostic and therapeutic dilemmas in managing women with thyroid disease during the menopausal transition, aiming to increase healthcare professionals' awareness of thyroid disorders and menopause-related symptoms. Clinical decisions regarding the treatment of both conditions should be made with caution and attention to the specific characteristics of this age group while adopting a personalized patient approach. The latter must include the family history, involvement of the woman in the decision-making, and respect for her preferences, to achieve overall well-being.